Fischer M, Böttiger B W, Popov-Cenic S, Hossmann K A
Max-Planck-Institute for Neurological Research, Department of Experimental Neurology, Köln, Germany.
Intensive Care Med. 1996 Nov;22(11):1214-23. doi: 10.1007/BF01709339.
Successful resuscitation of the brain requires complete microcirculatory reperfusion, which, however, may be impaired by activation of blood coagulation after cardiac arrest. The study addresses the question of whether postischemic thrombolysis is effective in reducing cerebral no-reflow phenomenon.
14 adult normothermic cats were submitted to 15-min cardiac arrest, followed by cardiopulmonary resuscitation (CPR) and 30 min of spontaneous recirculation. The CPR protocol included closed-chest cardiac massage, administration of epinephrine 0.2 mg/kg, bicarbonate 2 mEq/kg per 30 min, and electrical defibrillation shocks.
During CPR, animals in the treatment group (n = 6) received intravenous bolus injections of 100 U/kg heparin and 1 mg/kg recombinant tissue type plasminogen activator (rt-PA), followed by an infusion of rt-PA 1 mg/kg per 30 min.
Microcirculatory reperfusion of the brain was visualized by labeling the circulating blood with 300 mg/kg of 15% fluorescein isothiocyanate albumin at the end of the recirculation period. Areas of cerebral no-reflow--defined as the absence of microvascular filling--were identified by fluorescence microscopy at eight standard coronal levels of forebrain, and expressed as the percentage of total sectional area. One animal in the treatment group was excluded from further analysis because of intracerebral hemorrhage due to brain injury during trepanation. Autopsy revealed the absence of intracranial, intrathoracic, or intra-abdominal bleeding in all the other animals. In untreated animals (n = 8), no-reflow affected 28 +/- 13% of total forebrain sectional areas, and only 1 out of 8 animals showed homogenous reperfusion (i.e., no-reflow < 15% of total forebrain sectional areas). Thrombolytic therapy (n = 5) significantly reduced no-reflow to 7 +/- 5% of total forebrain sectional areas and all treated animals showed homogenous reperfusion at the microcirculatory level.
The present data demonstrate that thrombolytic therapy improves microcirculatory reperfusion of the cat brain when administered during reperfusion after cardiac arrest.
成功的脑复苏需要完全的微循环再灌注,然而,心脏骤停后凝血激活可能会损害这种再灌注。本研究探讨缺血后溶栓是否能有效减少脑无再流现象。
14只成年常温猫经历15分钟心脏骤停,随后进行心肺复苏(CPR)和30分钟的自主循环。CPR方案包括闭胸心脏按摩、静脉注射0.2mg/kg肾上腺素、每30分钟静脉注射2mEq/kg碳酸氢钠以及电击除颤。
在CPR期间,治疗组(n = 6)的动物静脉推注100U/kg肝素和1mg/kg重组组织型纤溶酶原激活剂(rt-PA),随后每30分钟输注1mg/kg rt-PA。
在再循环期结束时,通过静脉注射300mg/kg 15%异硫氰酸荧光素白蛋白标记循环血液,观察脑微循环再灌注情况。通过荧光显微镜在前脑的八个标准冠状层面确定脑无再流区域(定义为无微血管灌注),并以总面积的百分比表示。治疗组中有1只动物因开颅时脑损伤导致脑出血而被排除在进一步分析之外。尸检显示其他所有动物均无颅内、胸腔内或腹腔内出血。在未治疗的动物(n = 8)中,无再流影响了前脑总面积的28±13%,8只动物中只有1只显示均匀再灌注(即无再流<前脑总面积的15%)。溶栓治疗组(n = 5)无再流显著减少至前脑总面积的7±5%,所有接受治疗的动物在微循环水平均显示均匀再灌注。
目前的数据表明,在心脏骤停后的再灌注期间进行溶栓治疗可改善猫脑的微循环再灌注。